Krabbe Disease Clinical Trial
Official title:
A Phase 1/2 Clinical Study of Intravenous Gene Transfer With an AAVrh10 Vector Expressing GALC in Krabbe Subjects Receiving Hematopoietic Stem Cell Transplantation (RESKUE)
This is a nonblinded, non-randomized dose escalation study of intravenous AAVrh10 after hematopoietic stem cell transplantation (HSCT) in which subjects will receive standard of care hematopoietic cell transplantation for Krabbe disease, followed by a single infusion of an adeno-associated virus gene therapy product. Extensive natural history subjects will be used to compare as control group.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02993796 -
Krabbe Disease Global Patient Registry
|
||
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Terminated |
NCT00668564 -
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
|
Phase 2 | |
| Not yet recruiting |
NCT06308718 -
Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients
|
||
| Active, not recruiting |
NCT02699190 -
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
|
||
| Completed |
NCT01938014 -
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
|
||
| Recruiting |
NCT03333200 -
Longitudinal Study of Neurodegenerative Disorders
|
||
| Recruiting |
NCT05739643 -
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03047369 -
The Myelin Disorders Biorepository Project
|
||
| Completed |
NCT01043640 -
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
|
Phase 2 | |
| Withdrawn |
NCT01425489 -
Biomarker for Krabbe Disease (BioKrabbe)
|
||
| Active, not recruiting |
NCT00787865 -
Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease
|